Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-emptive Single Intravenous Lidocaine Dose to Prevent Post-Fundal Pressure Headache During Cesarean Section: The LID-HEAD Multi-center Randomized Controlled Trial

NCT07661758 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07661758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-emptive Single Intravenous Lidocaine Dose to Prevent Post-Fundal Pressure Headache During Cesarean Section: The LID-HEAD Multi-center Randomized Controlled Trial
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Recruiting
Start date
July 1, 2026
Completion date
November 2, 2026
Enrollment
680 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fundal pressure, headache, intravenous lidocaine